Reimbursement Landscape Assessment for Medical Technology

A reimbursement landscape assessment helps MedTech teams understand how coding, coverage, payment, evidence expectations, and payer variation may affect market access before major commercial decisions are locked in.
The appropriate reimbursement path depends on the product, target population, site of care, existing codes and payment mechanisms, available evidence, and the stakeholders whose decisions matter. A landscape assessment helps clarify which pathways are plausible and what evidence gaps could limit them.
Different reimbursement pathways carry different levels of evidence burden, timing, uncertainty, and investment. Combining reimbursement expertise with payer intelligence can help prioritize the sequence of actions and reduce avoidable market-access risk.

Regulatory authorization or a billing code alone does not establish reimbursement. Coding, coverage, and payment have to align, and payer evidence-review processes can vary by organization, benefit structure, technology type, and population.
Clinical-expert and stakeholder input can strengthen a reimbursement strategy by clarifying unmet need, current practice, implementation considerations, and the evidence questions decision-makers are likely to raise.
Payment models and contracting approaches continue to evolve. Reimbursement planning should therefore account for both current coding and payment mechanics and the value evidence that may matter in alternative payment or contracting discussions.

TTi can develop a reimbursement landscape assessment that maps the coding, coverage, and payment environment around your technology and explains how those elements interact for the target population, site of care, and commercial pathway.
For teams that already understand the basic reimbursement environment, we can perform a more focused review of how the product fits within existing pathways, where the evidence or policy gaps are, and which issues should be addressed before payer engagement or launch planning.
If you require support in developing a successful reimbursement strategy, our experts can conduct reimbursement assessments, or review findings from existing assessments, and build payer advisory boards comprised of current and former medical policy influencers to develop, assess, and/or validate your strategy. Reimbursement assessments and advisory boards can also identify appropriate sources of coverage, define elements of reimbursement (coding, coverage, and payment), define potential reimbursement pathways, and refine payer implementation timelines for your technology.

Insights

TTi Health Research & Economics2026-08-10T12:43:41-04:00August 10, 2026|Blog, Featured|

One Study Is Not an Evidence Strategy: Why MedTech Companies Need an Evidence Roadmap [...]

Why Good Clinical Data Still Fails to Win Coverage One of the hardest [...]

Why Founders Underestimate Protocol Design One of the first questions I ask founders [...]